본문 바로가기 주메뉴 바로가기
국회도서관 홈으로 정보검색 소장정보 검색

결과 내 검색

동의어 포함

목차보기

목차 1

Direct assay of induronate-2-sulfatase for hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate / 희귀질환 진단치료기술 연구·지원센터 편 1

[본문] 1

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
DUOX2 Mutations are frequently associated with congenital hypothyroidism in the Korean population 희귀질환 진단치료기술 연구·지원센터 [편] pp.4-5

보기
Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer : multifactorial probability-based model vs. ACMG standards and guidelines for the interpretation of sequence variants 희귀질환 진단치료기술 연구·지원센터 [편] pp.6-8

보기
(A) simple and rapid method based on liquid chromatography-tandem mass spectrometry for the measurement of α-L-iduronidase activity in dried blood spots : an application to mucopolysaccharidosis Ⅰ(Hurler) screening 희귀질환 진단치료기술 연구·지원센터 [편] pp.9-9

보기
Direct assay of iduronate-2-sulfatase for hunter disease using UPLC-tandem mass spectrometry and fluorogenic substrate 희귀질환 진단치료기술 연구·지원센터 [편] pp.10-10

보기
Breakpoint mapping by whole genome sequencing identifies PTH2R gene disruption in a patient with midline craniosynostosis and a de novo balanced chromosomal rearrangement 희귀질환 진단치료기술 연구·지원센터 [편] pp.11-11

보기
Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology 희귀질환 진단치료기술 연구·지원센터 [편] pp.12-12

보기
Tandem mass spectrometry has a larger analytical range than fluorescence assays of lysosomal enzymes : application to newborn screening and diagnosis of mucopolysaccharidoses types II, IVA, and VI 희귀질환 진단치료기술 연구·지원센터 [편] pp.13-13

보기
Isit fabry disease? 희귀질환 진단치료기술 연구·지원센터 [편] pp.14-14

보기
Inborn errors of metabolism collaborative : large-scale collection of data on long-term follow-up for newborn-screened conditions 희귀질환 진단치료기술 연구·지원센터 [편] pp.15-15

보기